Medicare Enrolled

Dr. Nabeel Sarhill, MD

Internal Medicine · Harlingen, TX
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
2121 PEASE ST STE 101, Harlingen, TX 78550
9564258845
Registered in NPPES since 2006
NPI: 1811098304 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Sarhill from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Sarhill? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Sarhill

Dr. Nabeel Sarhill is an internal medicine specialist in Harlingen, TX, with 19 years of NPI registration. Based on federal Medicare data, Dr. Sarhill performed 59,326 Medicare services in 2023. These records do not provide a deduplicated patient total.

Between the years covered by Open Payments, Dr. Sarhill received a total of $2,952 from 46 pharmaceutical and/or device companies across 123 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Sarhill is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years of NPI registration ▲ Top 1% volume in TX $2,952 industry payments

Medicare Practice Summary — 2023

Medicare Utilization ↗
59,326
Medicare services
Top 1% in TX for internal medicine
Not available
Unique patients (not deduplicated)
$8
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Iron sucrose injection (Venofer)
An injection of iron sucrose used to replenish iron levels in the body.
29,100 $0 $2
Darbepoetin injection (Aranesp) for anemia
An injection of darbepoetin alfa used for non-end-stage renal disease purposes.
9,395 $2 $20
Denosumab injection (Prolia/Xgeva) 5,400 $18 $66
Contrast dye for imaging (iodine-based)
A contrast agent containing 300-399 mg/ml of iodine used to enhance imaging studies. It is administered per milliliter to improve the visibility of internal structures.
3,500 $0 $3
Dexamethasone injection (steroid)
An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram.
1,665 $0 $1
Epoetin alfa injection (Retacrit) for anemia
An injection of a biosimilar form of epoetin alfa used for non-end-stage renal disease purposes. The dose administered is 1000 units.
1,180 $6 $28
Complete blood count (CBC) with differential
An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells.
1,101 $8 $36
Blood draw (venipuncture)
Insertion of a needle into a vein to collect a blood sample.
1,011 $8 $20
Comprehensive metabolic blood panel
A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers.
874 $10 $64
Injection, granisetron hydrochloride, 100 mcg 790 $0 $24
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
742 $87 $368
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
732 $60 $247
Injection, leucovorin calcium, per 50 mg 495 $3 $25
Fluorouracil injection, 500 mg
Administration of a 500 mg dose of fluorouracil medication via injection.
377 $2 $13
Additional sequential IV infusion, 1 hour or less
This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less.
259 $21 $157
Anti-nausea injection (Aloxi/palonosetron) 250 $1 $114
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
224 $10 $96
Intravenous chemotherapy infusion, 1 hour or less
Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete.
207 $96 $707
Intravenous infusion, 1 hour or less
Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less.
184 $44 $313
Ferritin level test (iron stores)
A blood test that measures the level of ferritin, a protein that stores iron in the body.
168 $13 $60
Iron level test 168 $6 $27
Iron binding capacity test
A blood test that measures the amount of iron in the blood and the blood's ability to bind and transport iron.
168 $9 $35
Zoledronic acid injection, 1 mg
An injection of zoledronic acid administered at a dose of 1 mg.
142 $6 $431
Initial hospital admission, high complexity
Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter.
114 $129 $694
New patient office visit, complex (60-74 min) 99 $153 $709
Reticulated platelet measurement
A blood test that measures the level of young, newly formed platelets in the body.
77 $35 $143
Ketorolac injection, per 15 mg
An injection of ketorolac tromethamine, a nonsteroidal anti-inflammatory drug, administered in doses measured per 15 mg.
74 $0 $4
Manual white blood cell count
A laboratory test that involves examining a sample under a microscope to manually count the number of white blood cells present.
73 $4 $22
Complete blood count (CBC), automated
An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood.
73 $6 $34
Additional hour of intravenous chemotherapy
This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period.
73 $20 $161
Irrigation of implanted venous access device
This procedure involves flushing an implanted venous access device to clear blockages or maintain patency. It ensures the device remains functional for delivering medications or fluids.
71 $17 $114
Intravenous infusion of new drug or substance, 1 hour or less
This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less.
67 $47 $344
Nuclear medicine scan from skull base to mid-thigh with CT
A nuclear medicine imaging study covering the area from the base of the skull to the middle of the thighs, performed alongside a CT scan.
61 $1,093 $4,802
Diphenhydramine injection, up to 50 mg
An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams.
60 $1 $7
Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries 58 $88 $657
Hospital follow-up visit, high complexity
Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter.
56 $90 $357
Subcutaneous or intramuscular chemotherapy injection
This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle.
34 $24 $145
Injection, fosnetupitant 235 mg and palonosetron 0.25 mg 33 $342 $1,722
PSA test (prostate cancer screening) 29 $18 $94
IV chemotherapy initiation with community continuation
Initiation of an intravenous chemotherapy infusion in a clinic using clinic supplies, with continuation of the infusion in a community setting such as home or assisted living.
26 $122 $500
Intravenous push injection of new drug or substance
A healthcare provider injects a new medication or substance directly into a vein using a push technique.
25 $42 $289
Basic metabolic blood panel
A blood test that measures a group of basic chemicals, including total calcium levels.
23 $8 $49
Bone marrow biopsy and aspiration
A procedure to remove a small sample of bone marrow and liquid for laboratory testing. The sample is analyzed to help diagnose various medical conditions.
19 $133 $523
CT scan of chest with contrast
A computed tomography scan of the chest using a contrast dye to enhance the visibility of internal structures.
18 $70 $821
CT scan of abdomen and pelvis with contrast
A CT scan that uses dye to create detailed images of the abdomen and pelvis. This imaging test helps doctors examine internal organs and structures in these areas.
16 $167 $1,067
Lactate dehydrogenase (LDH) level test
A blood test that measures the amount of lactate dehydrogenase, an enzyme found in many body tissues. It helps assess tissue damage or disease.
15 $6 $31
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
1.2% high complexity
89.3% medium
9.5% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$2,952
Total received (2018-2024)
Avg $422/year across 7 years
Top 24% in TX for internal medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
46
Companies
123
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$971
2023
$1,091
2022
$671
2021
$63
2020
$18
2019
$126
2018
$11

Payments by company (2024)

Astellas Pharma US Inc
$206
Eisai Inc.
$104
Daiichi Sankyo Inc.
$83
Apellis Pharmaceuticals, Inc.
$76
PFIZER INC.
$74
Regeneron Healthcare Solutions, Inc.
$53
Takeda Pharmaceuticals U.S.A., Inc.
$52
Celgene Corporation
$43
Boston Scientific Corporation
$36
Genmab U.S., Inc.
$30
ABBVIE INC.
$24
Genentech USA, Inc.
$22
E.R. Squibb & Sons, L.L.C.
$20
Bayer Healthcare Pharmaceuticals Inc.
$19
PUMA BIOTECHNOLOGY, INC.
$19
GlaxoSmithKline, LLC.
$18
BeiGene USA, Inc.
$17
Melinta Therapeutics, LLC
$16
Agios Pharmaceuticals, Inc.
$16
SOBI, INC
$15
EMD Serono, Inc.
$14
Janssen Biotech, Inc.
$14
Top 3 companies account for 40.5% of 2024 payments
All-time payments by company (2018-2024) ›
Astellas Pharma US Inc
$336
Seagen Inc.
$238
E.R. Squibb & Sons, L.L.C.
$238
PFIZER INC.
$169
Celgene Corporation
$152
Novartis Pharmaceuticals Corporation
$149
Janssen Biotech, Inc.
$131
Genentech USA, Inc.
$119
Eisai Inc.
$104
Apellis Pharmaceuticals, Inc.
$97
GlaxoSmithKline, LLC.
$88
Daiichi Sankyo Inc.
$83
Merck Sharp & Dohme LLC
$83
Lilly USA, LLC
$80
Boston Scientific Corporation
$54
Regeneron Healthcare Solutions, Inc.
$53
Takeda Pharmaceuticals U.S.A., Inc.
$52
Exelixis Inc.
$48
Karyopharm Therapeutics Inc.
$45
Deciphera Pharmaceuticals Inc.
$45
Amgen Inc.
$42
ABBVIE INC.
$42
Kyowa Kirin, Inc.
$36
Ipsen Biopharmaceuticals, Inc
$34
BeiGene USA, Inc.
$34
ADC Therapeutics America, Inc.
$31
Genmab U.S., Inc.
$30
Blue Earth Diagnostics Limited
$29
Merck Sharp & Dohme Corporation
$28
EMD Serono, Inc.
$26
Bayer Healthcare Pharmaceuticals Inc.
$19
PUMA BIOTECHNOLOGY, INC.
$19
TerSera Therapeutics LLC
$19
AVEO Pharmaceuticals, Inc.
$18
Bayer HealthCare Pharmaceuticals Inc.
$18
Mirati Therapeutics, Inc.
$17
ARRAY BIOPHARMA INC
$17
Melinta Therapeutics, LLC
$16
Agios Pharmaceuticals, Inc.
$16
Puma Biotechnology, Inc.
$16
Telix Pharmaceuticals
$16
SOBI, INC
$15
TAIHO ONCOLOGY, INC.
$15
Epizyme, Inc.,
$13
EISAI INC.
$13
Gilead Sciences, Inc.
$12
Top 3 companies account for 27.5% of all-time payments
Associated products mentioned in payments ›
ALUNBRIG · Alecensa · Axumin · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Bavencio · CABOMETYX · Cabometyx · Columvi · DARZALEX · DOPTELET · ELIQUIS · EPKINLY · Empaveli · Enhertu · Epkinly · FOTIVDA · GAZYVA · Gazyva · IBRANCE · ILLUCCIX · INLYTA · KEYTRUDA · KISQALI · KRAZATI · LIBTAYO · LONSURF · Lenvima · MEKINIST · Nplate · OJJAARA · OPDIVO · Onivyde · PADCEV · PIQRAY · POTELIGEO · PROMACTA · Pomalyst · QINLOCK · REBLOZYL · Rezzayo · SCEMBLIX · Somatuline Depot · SpaceOAR VUE System - 10mL · Stivarga · TASIGNA · TAZVERIK · TECVAYLI · TUKYSA · Tecentriq · TheraSphere Y90 Glass Microspheres 10 GBq · VENCLEXTA · VERZENIO · VPRIV · XGEVA · XPOVIO · XTANDI · Xospata · ZEJULA · Zoladex
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for an internal medicine specialist in Harlingen?
Compare internal medicine physicians in the Harlingen area by procedure volume, costs, and industry payment transparency.
Browse internal medicine physicians nearby

Geographic Context

Internal medicine physicians in nearby ZIP areas
122
County median income
$51,334
Nearest hospital to ZIP centroid (approximate)
VHS HARLINGEN HOSPITAL COMPANY LLC
0.0 mi

Data Sources

Provider Registry ✓ NPPES NPPES snapshot; verify current record
Medicare Enrollment ✓ PECOS PECOS snapshot
Practice Data ✓ Medicare Util. Annual (CY lag)
Industry Payments ✓ Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Sarhill is a mixed practice specialist, with above-average Medicare volume (top 1% in TX), with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Sarhill experienced with iron sucrose injection (venofer)?
Based on Medicare claims data, Dr. Sarhill performed 29,100 iron sucrose injection (venofer) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Sarhill receive payments from pharmaceutical companies?
Yes. Dr. Sarhill received a total of $2,952 from 46 companies across 123 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Sarhill's costs compare to other internal medicine physicians in Harlingen?
Dr. Sarhill's average Medicare payment per service is $8. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Sarhill) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →